AU2006269917A1 - New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide - Google Patents

New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide Download PDF

Info

Publication number
AU2006269917A1
AU2006269917A1 AU2006269917A AU2006269917A AU2006269917A1 AU 2006269917 A1 AU2006269917 A1 AU 2006269917A1 AU 2006269917 A AU2006269917 A AU 2006269917A AU 2006269917 A AU2006269917 A AU 2006269917A AU 2006269917 A1 AU2006269917 A1 AU 2006269917A1
Authority
AU
Australia
Prior art keywords
sulfate salt
single crystalline
crystalline form
pharmaceutical composition
isopropoxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006269917A
Other languages
English (en)
Inventor
Mark D. Angelino
Craig Grant
Hoa Q. Luong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2006269917A1 publication Critical patent/AU2006269917A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2006269917A 2005-07-20 2006-07-20 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide Abandoned AU2006269917A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70092605P 2005-07-20 2005-07-20
US60/700,926 2005-07-20
PCT/US2006/028231 WO2007012042A1 (en) 2005-07-20 2006-07-20 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide

Publications (1)

Publication Number Publication Date
AU2006269917A1 true AU2006269917A1 (en) 2007-01-25

Family

ID=37188923

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006269917A Abandoned AU2006269917A1 (en) 2005-07-20 2006-07-20 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide

Country Status (7)

Country Link
US (1) US20100179162A1 (enExample)
EP (1) EP1904459A1 (enExample)
JP (1) JP2009502804A (enExample)
CN (1) CN101208310A (enExample)
AU (1) AU2006269917A1 (enExample)
CA (1) CA2612459A1 (enExample)
WO (1) WO2007012042A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100273808A1 (en) * 2008-11-21 2010-10-28 Millennium Pharmaceticals, Inc. Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
JP2014513044A (ja) * 2011-02-10 2014-05-29 マイラン ラボラトリーズ リミテッド ホスアンプレナビルカルシウム結晶およびその調製方法
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
CN109549941A (zh) * 2017-09-26 2019-04-02 广西梧州制药（集团）股份有限公司 一种吡唑并嘧啶衍生物在制备治疗疾病药物方面的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US642376A (en) * 1898-10-24 1900-01-30 John W Skilton Car-axle box.
WO1998014431A1 (en) * 1996-10-01 1998-04-09 Kyowa Hakko Kogyo Co., Ltd. Nitrogenous heterocyclic compounds
JP3011904B2 (ja) * 1997-06-10 2000-02-21 明久 井上 金属ガラスの製造方法および装置
EP1309568B1 (en) * 2000-08-18 2011-02-16 Millennium Pharmaceuticals, Inc. [(quinazolin-4-yl)piperazin-4-yl]thiocarboxamide compounds as inhibitors of the phosphorylation of a PDGF receptor
MXPA03001359A (es) * 2000-08-18 2004-12-13 Millennium Pharm Inc Derivados de quinazolina como inhibidores de cinasa.
WO2002016362A2 (en) * 2000-08-18 2002-02-28 Cor Therapeutics, Inc. Nitrogenous heterocyclic compounds
ATE502928T1 (de) * 2000-11-01 2011-04-15 Millennium Pharm Inc Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
US20040259881A1 (en) * 2001-02-02 2004-12-23 Anjali Pandey Nitrogenous heterocyclic compounds
AU2002254152A1 (en) * 2001-03-08 2002-09-24 Millennium Pharmaceuticals (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases
US7456189B2 (en) * 2003-09-30 2008-11-25 Boehringer Ingelheim International Gmbh Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation

Also Published As

Publication number Publication date
CA2612459A1 (en) 2007-01-25
CN101208310A (zh) 2008-06-25
JP2009502804A (ja) 2009-01-29
EP1904459A1 (en) 2008-04-02
US20100179162A1 (en) 2010-07-15
WO2007012042A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
JP5043825B2 (ja) Ｄｐｐ−ｉｖ阻害剤の新規な塩及び多形
KR20120051702A (ko) Ｎ-〔３-플루오로-４-(｛６-(메틸옥시)-７-〔(３-모르폴린-４-일프로필)옥시〕퀴놀린-４-일｝옥시)페닐〕-ｎ''-(４-플루오로페닐)시클로프로판-１,１-디카르복사미드의 결정형
EP2548879A1 (en) Crystal of diamine derivative and method of producing same
JP2025148406A (ja) アクチビン受容体様キナーゼ阻害剤の塩及び結晶形態
CN113966332A (zh) Cdk9抑制剂的多晶型物及其制法和用途
US11124519B2 (en) Cocrystal forms of ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl) methyl sulfamate, formulations and uses thereof
EP4438613A1 (en) Mono-p-toluenesulfonate of axl kinase inhibitor and crystal form thereof
JP2013537901A (ja) アプレピタントｌ−プロリン組成物および共結晶
US20100179162A1 (en) Crystal forms of 4-[6-methoxy-7(3-piperidin-1-yl-propoxy) quinazoline-4yl) piperazine-1-carboxylic acid (4-isopropoxyphenyl)-amide
JP7743028B2 (ja) キナーゼ阻害剤として使用される化合物およびその使用
KR20210148110A (ko) Jak2 저해제의 결정 형태
BG106869A (bg) Мезилат на 4-амино-6,7-диметокси-2-/5-метансулфонамидо-1,2,3,4-тетрахидроизохинол-2-ил/-5-/2-пиридил/хиназолин и полиморфни форми
CN102666528B (zh) 晶体cdc7 抑制剂盐
HK40069001A (en) Salt and crystal forms of an activin receptor-like kinase inhibitor
TWI846516B (zh) Cdk9抑制劑的多晶型物及其製法和用途
HK40064722A (en) Polymorph of cdk9 inhibitor and preparation method for polymorph and use thereof
JP2022524741A (ja) セリネクソールの共結晶形態
HK40063558B (zh) 苯幷噻唑化合物的药用盐、多晶型物及其制备方法
HK1180341A (en) Crystal of diamine derivative and method of producing same

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period